News
59m
Cryptopolitan on MSNUS, Asian, and European stocks surge even after Trump’s new tariff collectionStocks from New York to Tokyo to Frankfurt rallied Thursday, even as President Trump slapped new tariffs on imports from India and South Korea, escalating his ...
Sanofi’s SAR446523, a GPRC5D monoclonal antibody, earns orphan drug designation in the US for multiple myeloma Designation granted for IgG1-based GPRC5D monoclonal antibody for the potential treatment ...
Sanofi’s Sarclisa approved in the EU for the treatment of transplant-eligible newly diagnosed multiple myeloma Approval based on GMMG-HD7 phase 3 study demonstrating that Sarclisa with VRd induction ...
4don MSN
Vertiv (NYSE:VRT) has agreed to acquire the Great Lakes Data Racks & Cabinets family of companies for $200 million. Vicebio, ...
Palo Alto Networks' (PANW) potential acquisition of CyberArk (CYBR) would complement Palo Alto's existing and bolster its ...
4h
Stocktwits on MSNNasdaq Futures Spike As Meta, Microsoft Earnings Outweigh Hawkish Fed — Strategist Warns Of Potential ‘Summer Swoon’Big tech earnings have inspired a substantial rise in Nasdaq futures in overnight trading after the Federal Reserve, led by ...
Thermo Fisher Scientific (TMO) recently unveiled two new electron microscopes, Scios 3 and Talos 12, at the Microscopy & Microanalysis conference, reinforcing their advanced technology offerings. The ...
Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today announced that the ...
HHS Secretary Robert F. Kennedy Jr. said he will work with Attorney General Pam Bondi to reform the National Vaccine Injury ...
3don MSN
Currently, a multidistrict litigation against Pfizer (NYSE: PFE) is underway on behalf of women who claim to have developed meningiomas after receiving four or more consecutive injections of ...
You should probably be saving more, but even if you can't do that, you can get more out of the money you are able to save.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results